Malawi: Jica Donates Ppes to Ministry of Health
[Nyasa Times] Japan International Cooperation Agency (JICA) has donated Personal Prevention Equipments (PPEs) to the Ministry of Health (MoH) to support in fighting against the spread of Covid-19 pandemic in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 23, 2020 Category: African Health Source Type: news

Fourth-Largest U.S. School District to Allow Students Back in Classrooms
Over 200,000 people have died in the U.S. from the coronavirus, a staggering toll. Japanese researchers suggest plastic face shields are insufficient to reduce the virus ’s spread. (Source: NYT Health)
Source: NYT Health - September 23, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

Plastic face shields DON'T work
Lead researcher Lakoto Tsubokura, from the Riken Centre in Japan, said he would not recommend wearing face shields in the place of face masks. His simulations revealed they offer limited protection. (Source: the Mail online | Health)
Source: the Mail online | Health - September 23, 2020 Category: Consumer Health News Source Type: news

Antenatal pain, intimate partner violence, and maternal bonding disorder: data from the Japan environment and children's study - Yamada K, Kimura T, Cui M, Kubota Y, Tanaka E, Wakaizumi K, Ikehara S, Kimura T, Iso H, Japan Environment and Children ’s Study Group.
This prospective study examined 1) whether antenatal pain is associated with postnatal maternal bonding disorder (MBD) through postnatal depression and 2) whether intimate partner violence (IPV) has a moderating effect on the association between antenatal ... (Source: SafetyLit)
Source: SafetyLit - September 23, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Bharat Biotech inks pact with WU's School of Medicine for COVID-19 intranasal vaccine
According to a press release issued by the city-based vaccine maker, Bharat Biotech owns the rights to distribute the vaccine in all markets except the US, Japan and Europe. While the Phase I trials will take place in St Louis University's Vaccine and Treatment Evaluation Unit, Bharat Biotech, upon obtaining the required regulatory approval, will pursue further stages of clinical trials in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

Sun Pharma arm launches plaque psoriasis treatment drug in Japan
In a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection 100 mg Syringe in Japan for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

Face shields ineffective at trapping aerosols, says Japanese supercomputer
Simulation using world ’s fastest supercomputer casts doubt on effectiveness in preventing spread of coronavirusCoronavirus – latest updatesSee all our coronavirus coveragePlastic face shields are almost totally ineffective at trapping respiratory aerosols, according to modelling inJapan, casting doubt on their effectiveness in preventing the spread ofcoronavirus.A simulation using Fugaku, the world ’s fastest supercomputer, found that almost 100% of airborne droplets of less than 5 micrometres in size escaped through plastic visors of the kind often used by people working in service industries.Continue r...
Source: Guardian Unlimited Science - September 22, 2020 Category: Science Authors: Justin McCurry in Tokyo Tags: Japan Coronavirus outbreak Asia Pacific World news Infectious diseases Science Medical research Source Type: news

Radiosurgery Appears to Benefit Old & Young With Brain Metastases Radiosurgery Appears to Benefit Old & Young With Brain Metastases
Stereotactic radiosurgery provides similar overall survival in patients older and younger than 75 years who have brain metastases from lung cancer, according to a retrospective study from Japan.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 22, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Novel coronavirus (CoViD-19) knowledge, precaution practice, and associated depression symptoms among university students in Korea, China, and Japan - Zhao B, Kong F, Aung MN, Yuasa M, Nam EW.
This study assessed university students' knowledge and precaution practices of Novel Coronavirus (COVID-19) in South Korea, China, and Japan, and investigated their depressive states during the pandemic. This cross-sectional survey collected data from 821 ... (Source: SafetyLit)
Source: SafetyLit - September 21, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Why East Asians Were Wearing Masks Long Before COVID-19
As the coronavirus pandemic's toll rises, here's what Americans can learn from countries such as China, Japan and South Korea about the humble face mask. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 19, 2020 Category: Consumer Health News Source Type: news

Fortis and Religare 'vehemently' oppose sale of trademarks in Delhi High Court
The court has been hearing a petition filed by Japanese drug firm Daiichi Sankyo seeking to attach and sell trademarks of Fortis and Religare and recover the amount due to it as per the Singapore tribunal arbitral award passed in April 2016. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Forgotten dreams: REM sleep helps prevent information overload, explain scientists
(Natural News) Dreams are quickly forgotten the moment people wake up. This is likely due to a group of neurons that gets activated during rapid eye movement (REM) sleep – the phase of mammalian slumber when most dreams are made. A recent study published in the journal Science examined the neurons that produce appetite and sleep hormones in mice. Japanese... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2020 Category: Consumer Health News Source Type: news

Takeda-Led COVID-19 Plasma Product to Begin Trial This Month Takeda-Led COVID-19 Plasma Product to Begin Trial This Month
An experimental COVID-19 therapy using blood plasma, developed by Japan's Takeda Pharmaceutical Co and its partners, is scheduled to begin a late-stage clinical trial after initial delays.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemi c therapy. Based on this recommendation, a final decision regarding approval of Tecentriq in combination with Avastin in this disease setting, along with the full details of the approved indication, is expe...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemi c therapy. Based on this recommendation, a final decision regarding approval of Tecentriq in combination with Avastin in this disease setting, along with the full details of the approved indication, is expe...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news

UK and Japan award eight Regenerative Medicine projects
In this landmark collaboration, MRC and AMED will make almost£7 million available to support collaborative projects that seek to advance regenerative approaches towards clinical use. (Source: Medical Research Council General News)
Source: Medical Research Council General News - September 17, 2020 Category: Research Source Type: news

Toyota reveals plan to turn trucks into emissions-free 'power plants'
Carmaker is to begin testing proposal to fit its Dyna vehicles with hydrogen fuel cellsPortable emissions-free “power plants” could soon hit the road under plans by Toyota to fit some of the company’s light-duty trucks with hydrogen fuel cells that can generate electricity.The world ’s second-largest carmaker will begin testing the plan to fit a Toyota Dyna with hydrogen fuel cells in Japan later this month, a move that could create fleets of temporary, mobile electricity sources worldwide.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 17, 2020 Category: Science Authors: Jillian Ambrose Tags: Toyota Automotive industry Business Hydrogen power Energy Environment Renewable energy Motoring Green economy Technology Climate change Science Source Type: news

Accuray Radixact(R) System with Synchrony(R) Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
First lung case in ASIA, and the first liver case in the world, were treated at Takarazuka City Hospital, Hyogo, Japan Japanese Red Cross Nagoya Daini Hospital, Aichi, and Kishiwada Tokushukai Hospital, Osaka, Japan, have started treating lung cases ... Devices, Oncology Accuray, Radixact System, Synchrony, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 – Possible Human Rights Crisis in Asia as Disparities Expected to Widen
The Asian Population and Development Association (APDA) is concerned by the societal socio-economic impact COVID-19 has created in the region, including the impact on employment and in unpaid care work, impact on health, including reproductive health services, and the impact of domestic violence during lockdowns. Credit: Bhuwan Sharma/IPS By Cecilia RussellJOHANNESBURG, South Africa, Sep 17 2020 (IPS) The negative impact of the coronavirus pandemic is likely to be felt long after the COVID-19 health risk is resolved, a high-level meeting under the auspices of the Asian Population and Development Association (APDA), heard. ...
Source: IPS Inter Press Service - Health - September 17, 2020 Category: International Medicine & Public Health Authors: Cecilia Russell Tags: Aid Development & Aid Economy & Trade Editors' Choice Featured Headlines Health Population Poverty & SDGs TerraViva United Nations Trade & Investment Asian Population and Development Association (APDA) International Conference on P Source Type: news

Factors that associate Japanese university students' use of rear seat belts on general roads and expressways - Ogawa S, Hayashi K, Nakao H, Shinozaki H.
This study clarifies the prevalence of rear seat belt use among university students and explores the factors that influence seat belt use on general roads and expressways. Questionnaires were distributed to 1,091 students who attended health education lect... (Source: SafetyLit)
Source: SafetyLit - September 17, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

Chemoradiotherapy Raises Risk of Thoracic Vertebral Fracture Chemoradiotherapy Raises Risk of Thoracic Vertebral Fracture
Chemoradiotherapy for esophageal cancer increases the risk of thoracic vertebral fractures, researchers in Japan report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 15, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Evacuation awareness and behavior in the event of a tsunami in an aging society: an experience from the 2018 Hokkaido Eastern Iburi earthquake - Arimura M, Vinh Ha T, Kimura N, Asada T.
Of all natural disasters, the dual catastrophe of earthquake and tsunami is one of the most dangerous, due to the suddenness and unpredictability of these events. Hokkaido, the biggest island situated to the north of Japan, has a lower frequency of earthqu... (Source: SafetyLit)
Source: SafetyLit - September 15, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Confronting apocalyptic terrorism: lessons from France and Japan - Saiya N.
Terrorists who believe they have a role to play in bringing about the apocalypse pose a serious threat to countries around the world. In their quest to eradicate this especially pernicious form of terrorism, states, including liberal democratic ones, confr... (Source: SafetyLit)
Source: SafetyLit - September 15, 2020 Category: International Medicine & Public Health Tags: Violence and Weapons Issues Source Type: news

Astronomers Find Potential Sign of Life in Venus ’ Atmosphere
Astronomers have found a potential sign of life high in the atmosphere of neighboring Venus: hints there may be bizarre microbes living in the sulfuric acid-laden clouds of the hothouse planet. Two telescopes in Hawaii and Chile spotted in the thick Venutian clouds the chemical signature of phosphine, a noxious gas that on Earth is only associated with life, according to a study in Monday’s journal Nature Astronomy. Several outside experts — and the study authors themselves — agreed this is tantalizing but said it is far from the first proof of life on another planet. They said it doesn’t satisfy th...
Source: TIME: Science - September 14, 2020 Category: Science Authors: SETH BORENSTEIN / AP Tags: Uncategorized Space wire Source Type: news

Legal measures to prevent child abuse in Japan - Aotake M.
An ancient Japanese proverb, ʻhô wa katei ni irazuʼ, stated that the law should not interfere in family affairs1). Therefore, in Japan, legal measures to prevent child abuse were quite limited in the past. However, in the 1980s, when serious child abuse... (Source: SafetyLit)
Source: SafetyLit - September 12, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Scientists find an enzyme that facilitates grafting between different family species
(Nagoya University) Nagoya University bioscientist Michitaka Notaguchi and colleagues in Japan recently found that the tobacco plant Nicotiana promotes adhesion of tissue and can maintain grafts between a broad range of species. They also identified "β-1,4 glucanases " as a key molecule in facilitating tissue adhesion of grafts. Their findings could aid crop production and lessen impact on ecosystems. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 12, 2020 Category: International Medicine & Public Health Source Type: news

Fukushima Has Turned These Grandparents Into Avid Radiation Testers
After losing trust in official information, the Japanese public took it upon themselves to learn to measure for radioactive matter. Nearly a decade after the nuclear disaster, they're still testing.(Image credit: Claire Harbage/NPR) (Source: NPR Health and Science)
Source: NPR Health and Science - September 11, 2020 Category: Consumer Health News Authors: Kat Lonsdorf Source Type: news

Can the loco-check be used as a self-check tool for evaluating fall risk among older subjects? A prospective study - Shigematsu H, Wada M, Miyata S, Kisanuki O, Tatsumi H, Nishimori K, Hara R, Tanaka M, Kawasaki S, Suga Y, Yamamoto Y, Okuda A, Tanaka Y.
BACKGROUND: Japan has now become a super-aged society. Notably, as the Japanese society ages, the prevalence of falls, which represent an aging-related problem, has increased. Locomotive syndrome (LS) is a condition of decreased mobility due to locomotive ... (Source: SafetyLit)
Source: SafetyLit - September 11, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

New data further reinforce Roche ’s OCREVUS (ocrelizumab) as a highly effective treatment for people with multiple sclerosis
Basel, 11 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data that show OCREVUS® (ocrelizumab) is a highly effective treatment option for people with relapsing-remitting multiple sclerosis (RRMS) who experienced a suboptimal response to their prior disease modifying therapy (DMT). Subgroup analys is from the two-year open-label Phase IIIb CASTING study also demonstrates that patients benefit across a wide range of disease related and demographic subgroups, regardless of prior treatment background. Findings will be presented at MSVirtual2020, the 8th Joint Meeting of the Americas Committee...
Source: Roche Media News - September 11, 2020 Category: Pharmaceuticals Source Type: news

New data further reinforce Roche ’s OCREVUS (ocrelizumab) as a highly effective treatment for people with multiple sclerosis
Basel, 11 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data that show OCREVUS® (ocrelizumab) is a highly effective treatment option for people with relapsing-remitting multiple sclerosis (RRMS) who experienced a suboptimal response to their prior disease modifying therapy (DMT). Subgroup analys is from the two-year open-label Phase IIIb CASTING study also demonstrates that patients benefit across a wide range of disease related and demographic subgroups, regardless of prior treatment background. Findings will be presented at MSVirtual2020, the 8th Joint Meeting of the Americas Committee...
Source: Roche Investor Update - September 11, 2020 Category: Pharmaceuticals Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

New data show Roche ’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)
Basel, 10 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new ENSPRYNG ® (satralizumab) data on reducing relapse severity in the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare disease of the central nervous system. These data are being presented at MSVirtual2020, the 8th joint ACTRIMS-ECTRIMS meeting, in addition to longer-term efficacy data supporting the continued effect of ENSPRYNG on reducing the risk of NMOSD relapse, as well as its favourable benefit:risk profile.“The data for ENSPRYNG at MSVirtual2020 are promising and suggest it significantly reduces relapse severity ...
Source: Roche Media News - September 10, 2020 Category: Pharmaceuticals Source Type: news

New data show Roche ’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)
Basel, 10 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new ENSPRYNG ® (satralizumab) data on reducing relapse severity in the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare disease of the central nervous system. These data are being presented at MSVirtual2020, the 8th joint ACTRIMS-ECTRIMS meeting, in addition to longer-term efficacy data supporting the continued effect of ENSPRYNG on reducing the risk of NMOSD relapse, as well as its favourable benefit:risk profile.“The data for ENSPRYNG at MSVirtual2020 are promising and suggest it significantly reduces relapse severity ...
Source: Roche Investor Update - September 10, 2020 Category: Pharmaceuticals Source Type: news

FABP4: Preschool-aged biomarker discovered for autism spectrum disorder
(RIKEN) Researchers at the RIKEN Center for Brain Science in Japan have discovered a biomarker that can detect autism spectrum disorder (ASD) in preschool-aged children. The new study found that levels of the protein FABP4 were much lower in four- to six-year-old children with ASD than they were in other typically developing children. Experiments in mice that lacked FABP4 revealed changes in neurons that resemble those found in the postmortem brains of people with ASD. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 10, 2020 Category: International Medicine & Public Health Source Type: news

Roche expands its multiple sclerosis portfolio with investigational BTK inhibitor fenebrutinib and initiates novel clinical trials for OCREVUS (ocrelizumab)
Basel, 9 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of an innovative Phase III clinical trial programme for its investigational medicine fenebrutinib in multiple sclerosis (MS), along with a higher-dose Phase III clinical trial programme for OCREVUS® (ocrelizumab) and a distinct O CREVUS trial specifically to support African-American and Hispanic- and Latinx-American patients with MS. Overviews of clinical trials and scientific rationale will be presented at MSVirtual2020, the 8th Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTR...
Source: Roche Media News - September 9, 2020 Category: Pharmaceuticals Source Type: news

Roche expands its multiple sclerosis portfolio with investigational BTK inhibitor fenebrutinib and initiates novel clinical trials for OCREVUS (ocrelizumab)
Basel, 9 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of an innovative Phase III clinical trial programme for its investigational medicine fenebrutinib in multiple sclerosis (MS), along with a higher-dose Phase III clinical trial programme for OCREVUS® (ocrelizumab) and a distinct O CREVUS trial specifically to support African-American and Hispanic- and Latinx-American patients with MS. Overviews of clinical trials and scientific rationale will be presented at MSVirtual2020, the 8th Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTR...
Source: Roche Investor Update - September 9, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus live news: France confirms 6,544 new infections; Spain reports 3,168 new daily cases
Latest figures bring France ’stotal cases to 335,524 and Spain ’s to534,513; concerns over spread of virusin Greek migrant camps‘Not a game’: Europe pleads with young people to halt Covid spreadBrazil ’s ex-president Lula condemns Bolsonaro over CovidUS: death rate among African Americans and Latinos rising sharplyTour de France race director tests positiveTokyo Olympics must be held at ‘any cost’, says Japanese minister11.10pmBSTThe Welsh government has added three more Greek islands to its quarantine list just hours before restrictions come into force.From 4am on Wednesday, trave...
Source: Guardian Unlimited Science - September 9, 2020 Category: Science Authors: Jessica Murray (now); Sarah Marsh, Amelia Hill, Alexandra Topping and Helen Sullivan (earlier) Tags: Coronavirus outbreak World news UK news US news Australia news Science Infectious diseases Source Type: news

Japan Says It Will Bear Cost of Coronavirus Vaccines for Populace Japan Says It Will Bear Cost of Coronavirus Vaccines for Populace
Japan's government said on Friday it would bear the cost of providing coronavirus vaccines to the populace, as it aims for a comprehensive inoculation against the pandemic.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 8, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Coronavirus: What's happening around the world on Tuesday
The International Olympic Committee and Japanese organizers are trying to convince the public that the postponed Tokyo Olympics will take place next year despite the COVID-19 pandemic. Here's what's going on with the coronavirus around the world. (Source: CBC | Health)
Source: CBC | Health - September 8, 2020 Category: Consumer Health News Tags: News/World Source Type: news

Frailty status and transport disadvantage: comparison of older adults' travel behaviours between metropolitan, suburban, and rural areas of Japan - Abe T, Kitamura A, Seino S, Yokoyama Y, Amano H, Taniguchi Y, Nishi M, Nofuji Y, Ikeuchi T, Sugiyama T, Shinkai S.
This study examined differences in older adults' travel behaviours by frailty status in metropolitan, suburban, and rural areas of Japan. Data were collected from 9104 older adults (73.5 ± 5.7 years; 51% women; 19% frail) living in metropolitan (n = 5032)... (Source: SafetyLit)
Source: SafetyLit - September 8, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

A case of pediatric cyanoacrylate adhesive injury to the eye - Tsutsui A, Sugihara K, Tanito M.
A 5-year-old Japanese boy presented to the emergency room of our hospital because his right eye had been glued shut for 2 h following instillation of cyanoacrylate adhesive. The clinical examination showed redness of the right upper and lower lid skin; the... (Source: SafetyLit)
Source: SafetyLit - September 8, 2020 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients
Basel, 8 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) 510k clearance for the cobas ® BKV Test on the cobas® 6800 and 8800 Systems. The test was previously granted FDA Breakthrough Device designation demonstrating the improved treatment or diagnosis of life-threatening diseases or conditions for transplant patients. The test provides standardised, high-quality results that can he lp healthcare professionals better assess the risk of complications caused by the BK virus in transplant patients and identify effective treatment options. BK virus (BKV) is a m...
Source: Roche Investor Update - September 8, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients
Basel, 8 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) 510k clearance for the cobas ® BKV Test on the cobas® 6800 and 8800 Systems. The test was previously granted FDA Breakthrough Device designation demonstrating the improved treatment or diagnosis of life-threatening diseases or conditions for transplant patients. The test provides standardised, high-quality results that can he lp healthcare professionals better assess the risk of complications caused by the BK virus in transplant patients and identify effective treatment options. BK virus (BKV) is a m...
Source: Roche Media News - September 8, 2020 Category: Pharmaceuticals Source Type: news

MD Anderson and Astex Pharmaceuticals announce strategic collaboration to accelerate clinical evaluation of therapies for patients with leukemia
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announce a strategic collaboration agreement aimed at accelerating the clinical evaluation of Astex's pipeline of products for patients with certain types of leukemia, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML). The collaboration will combine MD Anderson's clinical trials infrastructure and expertise with Astex's clinical pipeline p...
Source: EurekAlert! - Cancer - September 8, 2020 Category: Cancer & Oncology Source Type: news

Long-term observational study on 6223 survivors of arsenic poisoning due to contaminated milk powder during infancy - Liu R, Tabuchi T, Kitamura T, Miyashiro I, Sobue T.
This study aimed to assess the mortality and cancer incidence risk among Japanese individuals who were poisoned durin... (Source: SafetyLit)
Source: SafetyLit - September 7, 2020 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Gene test can predict risk of medications causing liver injury
(Cincinnati Children's Hospital Medical Center) A team of scientists from Cincinnati Children's, Japan and Europe report in a study published Sept. 7, 2020, in Nature Medicine, identifying a 'polygenic risk score' that shows when a medication poses a risk of liver injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news

Viruses play critical role in evolution and survival of the species
(Cincinnati Children's Hospital Medical Center) New research in Nature Structural& Molecular Biology shows viruses also play a key evolutionary role in mammals' ability to reproduce and survive, according to scientists in the Cincinnati Children's Perinatal Institute and at Azabu University in Japan. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news

International registries show PCI rates increased in Japan, US
(American College of Cardiology) Japan and the US have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news